Clinical practice - Breath tests

British Medical Bulletin

Volumn 54, Issue 1, 1998, Pages 187-193

  Bell, G D ^a,b  

^a SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SUNDERLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; CARBON 14; CARBON DIOXIDE; CITRIC ACID; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; UREA; UREASE;

BREATH ANALYSIS; CLINICAL PRACTICE; GRAM NEGATIVE INFECTION; HEALTH CARE COST; HELICOBACTER PYLORI; HUMAN; ISOTOPE LABELING; LIQUID SCINTILLATION COUNTING; MASS SPECTROMETRY; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; TEST MEAL;

EID: 0031950638     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011669     Document Type: Review

References (26)

1. 13C-urea breath test. Lancet 1987; ii: 1174-7
2. 14C-urea breath test analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet 1987; i: 1367-8
3. Weil J, Bell GD, Gant P, Jones PH, Trowell JE, Harrison G. 'Eradication' of Campylobacter pylori: are we being misled? Lancet 1988; ii: 1245
4. Weil J, Bell GD, Powell KU et al. Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination. Aliment Pharmacol Ther 1990; 4: 651-7
5. Bell GD. Anti-Helicobacter pylori therapy: clearance, elimination or eradication? Lancet 1991; 337: 311
6. Weil J, Bell GD, Powell KU et al. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication. Aliment Pharmacol Ther 1991; 5: 309-13
7. Bell GD, Powell K, Burridge SM et al. Experience with 'Triple' anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment isolate for metronidazole resistance. Aliment Pharmacol Ther 1992; 6: 427-35
8. 14C-urea breath test. In: Rathbone BJ, Heatley RV. (Eds) Helicobacter pylori and Gastroduodenal Disease. Oxford: Blackwell, 1992; 74-87
9. Bell GD, Powell KU, Burridge SM et al. Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with 3 different forms of bismuth containing triple therapy. QJM 1993; 86: 743-50
10. Bell GD. Urea breath tests. In: Northfield TC, Mendall M, Coggin PM. (Eds) Helicobacter pylori Infection. Pathophysiology, Epidemiology and Management. Dordecht: Kluwer, 1993; 127-38
11. Bell GD, Powell KU, Burridge SM et al. Rapid eradication of Helicobacter pylori in ulcer disease. Aliment Pharmacol Ther 1995; 9: 41-6
12. 13Carbon urea breath test for Helicobacter pylori: comparison with histology, culture and ELISA serology. Gut 1991; 32: 1461-4
13. 13C-urea breath test for the detection of Helicobacter pylori. Eur J Gastroenterol Hepatol 1991; 3: 915-21
14. 13C-urea breath test. In: Rathbone BJ, Heatley RV. (Eds) Helicobacter pylori and Gastroduodenal Disease. Oxford: Blackwell, 1992; 88-106
15. Langenberg ML, Tytgat GN, Schipper MEI et al. Campylobacter-like organisms in the stomachs of patients and healthy individuals. Lancet 1984; i: 1348
16. Marshall BJ, Langton SR. Urea hydrolysis in patients with Campylobacter pyloridis infection. Lancet 1986; i: 965-6
17. McNulty CAM, Wise R. Rapid diagnosis of Campylobacter associated gastritis. Lancet 1985; ii: 1443-4
18. 14 urea breath test for the diagnosis of Campylobacter pylori-associated gastritis. J Nucl Med 1988; 29: 11-6
19. 14C-urea breath test in C. pylori gastritis. Gut 1989; 30: 798-803
20. Stubbs JB, Marshall BJ. Radiation dose estimates for the carbon 14-labelled urea breath test. J Nucl Med 1993; 34: 821-5
21. 13C-urea breath test for Helicobacter pylori infection. Gut 1991; 32: 551-2
22. 13C-urea breath test for the diagnosis of Helicobacter pylori infection. Gut 1997; 40: 459-62
23. 13C-urea breath test modifications still meet the criteria for valid diagnosis of Helicobacter pylori infection. Z Gastroenterol 1994; 32: 198-202
24. 13C-urea. Eur J Gastroenterol Hepatol 1990; 2: 437-44
25. 14C-urea breath rest for C. pylori. Gut 1989; 30: 1656-7
26. Bell GD, Powell KU. Helicobacter pylori reinfection after apparent eradication - the Ipswich experience. Scand J Gastroenterol 1996; 31 (Suppl 215): 96-104